πŸ‡ΊπŸ‡Έ FDA
Patent

US 6635764

Therapeutic ureas

expired A61PA61P1/00A61P1/02

Quick answer

US patent 6635764 (Therapeutic ureas) held by Theravance, Inc. expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00